Apple, Intel, and Oakland Raiders Marketing Veteran Courtnee Westendorf to Drive Growth and Company Promotes Noted Duke University Cardiologist Dr. Bimal
MOUNTAIN VIEW, Calif., January 16, 2019 — Livongo Health, the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced it has appointed Courtnee Westendorf as its Chief Marketing Officer and promoted Dr. Bimal Shah to Chief Medical Officer. These appointments are the latest in a series of recent key executive appointments to add to its experienced management team to support the company’s continued growth and market expansion. More than 700 of the largest, most innovative self-insured employers along with 4 of the top 7 health plans, leading health systems, and the two largest pharmacy benefit managers use Livongo’s platform to help people across the nation better manage their chronic conditions.
As Chief Marketing Officer, Westendorf will oversee all brand, communications, marketing, events, and digital activities for Livongo. She will report to Livongo’s President, Dr. Jennifer Schneider, M.D., M.S. Through her successful 25-year career in consumer marketing, Westendorf brings a unique perspective and broad skill set to Livongo. Westendorf most recently served as the Oakland Raiders Chief Marketing Officer. Prior to joining the Raiders, Westendorf served as Vice President of Marketing for Intel, redefining marketing partnerships for the company through unique engagements with some of the world’s leading sports properties. At Disney, she was Vice President of Consumer Marketing, responsible for developing and executing all go-to-market strategies for the Disney Interactive Media Group. Westendorf started her marketing career at Apple, where for more than ten years she led launch activities, brand management and consumer partnerships in support of the company’s launches of the iMac, iTunes, iPod, and iPhone and the iOS ecosystem.
Dr. Shah most recently served as Senior Vice President of Clinical Strategy for Livongo, leading the successful launch of the company’s Hypertension offering. Previously, Dr. Shah was the Chief Medical Officer for Emerging Technology and Informatics at Premier Inc. and served on the faculty at both the Department of Medicine and Fuqua School of Business at Duke University. He holds degrees from the University of North Carolina at Chapel Hill and Duke University. Dr. Shah completed his residency in Internal Medicine at Stanford University and remains on faculty at Duke as a practicing non-invasive cardiologist.
“We are excited to have a leading marketing executive like Courtnee join Livongo given her background building and expanding some of the world’s iconic brands,” said Glen Tullman, Executive Chairman of Livongo. “With the addition of Courtnee and promotion of Dr. Shah as our new Chief Medical Officer, Livongo continues to expand our leadership capacity and strength to meet the rapidly growing market demand for our Applied Health Signals solutions.”
In 2018, Livongo announced a new category of technologies and capabilities, Applied Health Signals, that for the first time combines data science, behavior enablement, and clinical impact to reinvent the healthcare experience for people with chronic conditions. Most people living with chronic conditions are not concerned about devices, big data, or analytics. Instead, they want a better experience that makes it easier to stay healthy with fewer tasks, and better information they can act on. As a leader in the Applied Health Signals category, Livongo gathers substantial amounts of data, turns it into actionable, personalized information, and offers it to health consumers at the right moment resulting in measurable behavioral change.
“Livongo has become the leading Applied Health Signals company with solutions to address the full axis of cardiometabolic conditions, including diabetes prevention along with weight, diabetes, and hypertension management. Dr. Shah has played a critical role in the development of our clinical solutions that are helping reinvent the chronic-condition experience,” said Dr. Schneider.
Livongo pioneered the category of Applied Health Signals, empowering people with chronic conditions to live better and healthier lives. Livongo’s team of data scientists aggregate and interpret substantial amounts of health data and information to create actionable, personalized, and timely health signals. Livongo is the first company at the intersection of data science, behavior enablement, and clinical impact with the technologies and capabilities to Silence Noisy Healthcare™. Our approach is leading to better clinical and financial outcomes while creating a different and better experience for people with chronic conditions. For more information, visit: www.livongo.com.